Randomized phase 0/I trial of the mitochondrial inhibitor Me-344 or placebo added to bevacizumab in early HER2-negative breast cancer
- Quintela-Fandino, M.
- Morales, S.
- Cortes-Salgado, A.
- Manso, L.
- Apala, J.V.
- Muñoz, M.
- Cudos, A.G.
- Fortuny, J.S.
- Gion, M.
- Lopez-Alonso, A.
- Cortes, J.
- Guerra, J.
- Malon, D.
- Caleiras, E.
- Mulero, F.
- Mouron, S.
ISSN: 1557-3265, 1078-0432
Argitalpen urtea: 2020
Alea: 26
Zenbakia: 1
Orrialdeak: 35-45
Mota: Artikulua